Personalized cancer vaccine for advanced cancer
Part of Cancer clinical trials.
This trial tests a personalized vaccine made from your cancer's unique markers. The goal is to train your immune system to fight the cancer, potentially slowing it down when other options have run out.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced cancer that has not responded to or is not eligible for standard treatments.
- Your cancer burden is low (not widespread or fast-growing) and you are expected to live more than 6 months.
- You are generally able to care for yourself (ECOG performance status of 2 or less).
- You are not pregnant or breastfeeding, and you do not have a severe autoimmune disease (except mild thyroid or mild psoriasis).
- You have not received treatments that severely damage T-cells (a type of immune cell), and you have not been in another interfering study within 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial offers access to a personalized vaccine made from your tumor's unique markers (neoantigens). The goal is to train your immune system to fight your cancer. You may qualify if standard treatments have not worked or are not an option, and your doctor believes your 5-year survival chance is under 50%.
This trial tests a personalized cancer vaccine made from synthetic long peptide “neoantigens,” aiming to be safe and help the immune system fight certain solid tumors. It may fit people with pancreatic cancer after starting first-line chemotherapy, and some other solid tumors with limited options.
This trial tests a personalized vaccine made from unique markers on your tumor cells (called neoantigens). The goal is to help your immune system fight the cancer more effectively. It is for people with advanced solid tumors who have not had gene therapy and are otherwise relatively healthy.
This trial tests a personalized vaccine made from your own immune cells (dendritic cells) to help your body fight advanced cancer. It is for people whose cancer has not responded to other treatments.
This trial tests a personalized vaccine made from “neoantigens” (tumor-specific targets) to help your immune system fight advanced, inoperable solid tumors. It may be an option if standard treatment didn’t work or you stopped it and your health is strong enough for trial treatment.
This trial tests a personalized cancer vaccine combined with a special type of radiation therapy for people with advanced or recurrent cancers that no longer respond to standard treatments. The goal is to help your immune system better recognize and attack your cancer.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.